To Evaluate the Safety and Efficacy of RP902 Tablets

Clinical trial NCT07579884 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07579884
Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)

Start date: 2026-07-01
Primary completion: 2029-05-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.